Variant report
Variant | nsv582990 |
---|---|
Chromosome Location | chr2:126383227-126395158 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200892675 | chr2:126391616-126391617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556929597 | chr2:126391673-126391674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529272117 | chr2:126391712-126391713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75084777 | chr2:126391733-126391734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150589312 | chr2:126391777-126391778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561605377 | chr2:126391781-126391782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527513861 | chr2:126391785-126391786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368907815 | chr2:126391786-126391787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541192661 | chr2:126391789-126391790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564154976 | chr2:126391790-126391791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547352308 | chr2:126391802-126391803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533029306 | chr2:126391838-126391839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549941429 | chr2:126391842-126391843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550793738 | chr2:126391845-126391846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373118803 | chr2:126391846-126391847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565657711 | chr2:126391865-126391866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563376466 | chr2:126391872-126391873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528855305 | chr2:126391911-126391912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12993771 | chr2:126391947-126391948 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs566336871 | chr2:126391962-126391963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535037633 | chr2:126391964-126391965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3962037 | chr2:126391991-126391992 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs3980655 | chr2:126392010-126392011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537547436 | chr2:126392015-126392016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556986895 | chr2:126392043-126392044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs4399732 | chr2:126392044-126392045 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs62158224 | chr2:126392085-126392086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140253073 | chr2:126392107-126392108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572281868 | chr2:126392123-126392124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541001339 | chr2:126392158-126392159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369620323 | chr2:126392170-126392171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35676767 | chr2:126392180-126392181 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs573591815 | chr2:126392181-126392182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578159813 | chr2:126392234-126392235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543651845 | chr2:126392260-126392261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563339671 | chr2:126392261-126392262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529020477 | chr2:126392290-126392291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548980315 | chr2:126392293-126392294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144214289 | chr2:126392314-126392315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116808800 | chr2:126392319-126392320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181573662 | chr2:126392370-126392371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571909165 | chr2:126392391-126392392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147790220 | chr2:126392449-126392450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550775803 | chr2:126392471-126392472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563307263 | chr2:126392518-126392519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567392269 | chr2:126392536-126392537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542544619 | chr2:126392593-126392594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553314765 | chr2:126392665-126392666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573196806 | chr2:126392688-126392689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534913776 | chr2:126392693-126392694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:126391600-126393000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr2:126392000-126392600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:126392000-126392800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:126392200-126392800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr2:126392200-126392800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr2:126392800-126393200 | Genic enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr2:126393200-126399200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |